MED, US58470S1024

Medifast refines its technical picture, shares trade in a narrow Nasdaq range

Published on 06/22/2026 at 19:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medifast sits between nearby support and resistance on Nasdaq, with several chart indicators pointing to a cautious technical setup for the MED shares.

MED, US58470S1024, Illustration mit AI erstellt.
MED, US58470S1024, Illustration mit AI erstellt.

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-22, 19:18.

Medifast (US58470S1024) remains a small-cap health and wellness name on the NYSE, with chart technicians watching a tight range between nearby support and resistance levels. Data from 18 June show the shares closing at 11.04 US dollars on New York trading.

What recent chart data show

On 18 June, Medifast last closed at 11.04 dollars, down 1.6 percent on the day, according to technical platform TradingKey, which tracks the NYSE listing. The service reports a market capitalization of about 122.76 million dollars at that close.

In the same technical snapshot, Medifast’s price momentum score stands at 5.43, ranking the stock 75th out of 95 names in the Food & Tobacco industry group. TradingKey’s model flags the overall daily signal as “Sell”, with 0 buy signals and 2 sell signals based on its indicator set.

Support, resistance and moving averages

Medifast shares currently trade between a documented resistance level at 12.55 dollars and support at 10.27 dollars on TradingKey’s range analysis. The provider characterizes this configuration as suited to range-bound swing trading strategies rather than clear trend-following approaches.

Looking across moving averages from 5-day to 200-day, TradingKey counts 0 buy signals and 6 sell signals for the stock. In combination with the negative daily signal, that places Medifast in the weaker half of its sector’s technical rankings, even if the absolute price level remains close to the noted support area.

Go deeper

Background and data on the Medifast shares

Key figures, historical news and regulatory filings provide additional context for the NYSE-listed Medifast equity beyond the current technical readings.

How Medifast earns its revenue

Medifast generates its revenue in the United States primarily through health and wellness products and programs that target weight management and lifestyle change. The company’s main consumer brand is Optavia, which combines portion-controlled meals with a coach-based behavior program, as highlighted in recent strategy overviews.

Where the shares trade today

The Medifast shares (US58470S1024) most recently closed on the NYSE at 11.04 US dollars on 2026-06-18 at 16:00 Eastern Time, based on TradingKey data.

Key data on the Medifast shares

  • Company: Medifast Inc.
  • ISIN: US58470S1024
  • WKN: 662385
  • Ticker: MED
  • Trading venue: NYSE
  • Price (as of 2026-06-18, 16:00): 11.04 USD
  • Market cap: 122.76 million USD (as of 2026-06-18)
  • Sector / industry: Consumer Staples / Packaged Foods & Meats, weight-management focus
  • Index membership: not a member of the S&P 500 or NASDAQ-100
  • Next earnings date: not officially scheduled

More on the Medifast shares in social media

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US58470S1024 | MED | boerse | 69605011 | bgmi